On April 25, 2012, one of the most recent against the Japanese-based pharmaceutical giant Takeda Pharmaceuticals was filed in the Louisiana Western District Court (case no. 6:2012cv01001). The plaintiff Donald Shingleton of West Virginia claims that the anti-diabetic drug Actos is directly linked to his developing bladder cancer. Shingleton began taking Actos in 2005 to help manage his Type 2 diabetes and is seeking compensation for injury and emotional distress.  Once filed, this case became part of Multidistrict Litigation (MDL) No. 2299, a procedure in which all civil cases of a similar type are transferred to one federal judge in order to save time and money. U. S. District Judge Rebecca Doherty of the Western U. S. District Court of Louisiana presides over more than 150 -related lawsuits.

Starting with the drug’s approval in July 1999, Takeda, along with its American business partner Eli Lilly